Exploiting the Features of Short Peptides to Recognize Specific Cell Surface Markers

Area of Science:

• Biomolecular Engineering
• Cell Biology
• Regenerative Medicine

Background:

• Antibodies are standard for biomarker recognition but have limitations like high cost and poor tissue penetration.
• Peptides offer advantages such as easier synthesis, modification, and tagging, despite lower initial biospecificity compared to antibodies.

Purpose of the Study:

• To design and identify peptide sequences that specifically recognize the CD44 hyaluronic acid receptor.
• To evaluate these peptides as potential alternatives to antibodies in biological assays and regenerative medicine.

Main Methods:

• Combined rational design and in silico methodologies to identify optimal peptide sequences.
• Synthesized and tested two designed peptide sequences on human bone marrow mesenchymal stromal cells (hBM-MSCs).
• Assessed peptide binding sensitivity and selectivity to the CD44 receptor.

Main Results:

• Identified two peptide sequences with potential for CD44 receptor recognition.
• One synthesized peptide demonstrated sensitive and selective binding to CD44 on hBM-MSCs.
• This peptide shows potential as an antibody alternative in immunostaining.

Conclusions:

• Developed a strategy for designing specific peptide binders using computational and rational approaches.
• The identified peptide offers a viable alternative to antibodies for CD44 detection.
• This peptide has applications in regenerative medicine, such as functionalizing scaffolds and cell sorting for MSC isolation.